Related Experiment Videos
Vaccine-associated fibrosarcoma in a cat
1Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1.
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne
|September 19, 2003
Summary
A vaccine-associated fibrosarcoma in a cat was successfully treated with radiation, surgery, and chemotherapy. The feline patient remained disease-free for 278 days post-treatment, indicating positive treatment outcomes.
Area of Science:
- Veterinary Oncology
- Feline Medicine
Background:
- Vaccine-associated sarcomas (VAS) are aggressive tumors in cats.
- Early and multimodal treatment is crucial for managing VAS.
Observation:
- An 8-year-old spayed female domestic shorthair presented with a vaccine-associated fibrosarcoma.
- The cat underwent radiation therapy, aggressive surgical excision, and postoperative chemotherapy.
Findings:
- Histopathology confirmed complete tumor excision.
- The cat experienced a favorable outcome, remaining disease-free for 278 days post-initial presentation.
Implications:
- This case highlights the efficacy of a combined therapeutic approach for feline vaccine-associated fibrosarcoma.
- Successful management suggests potential for improved prognosis in similar cases with prompt, aggressive intervention.